Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009

Antiviral Research

Volumn 84, Issue 2, 2009, Pages 199-202

  Choi, Woo Young ^a   Kim, SuJin ^a   Lee, NamJoo ^a   Kwon, Meehwa ^a   Yang, InSeok ^a   Kim, Min Ji ^a   Cheong, Seul Gi ^a   Kwon, Donghyok ^a   Lee, Joo Yeon ^a   Oh, Hee Bok ^a   Kang, Chun ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Amantadine resistance; Influenza A virus; Phylogenetic analysis; South Korea

Indexed keywords

AMANTADINE;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SOUTH KOREA; STRAIN DIFFERENCE;

AMANTADINE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS;

EID: 70349448404     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.08.006     Document Type: Article

References (11)

1. Abed Y., Goyette N., and Boivin G. Generation and characterization of recombinant influenza A(H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 49 (2005) 556-559
2. Barr I.G., Deng Y.M., Iannello P., et al. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antiviral Res. 80 (2008) 200-205
3. Bright R.A., Medina M.J., Xu X., et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366 (2005) 1175-1181
4. Centre for Disease Control Prevention (CDC). High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. MMWR Morb. Mortal. Wkly. Rep. 55 (2006) 44-46
5. Deyde V.M., Xu X., Bright R.A., et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 196 (2007) 249-257
6. Englund J.A. Antiviral therapy of influenza. Semin. Pediatr. Infect. Dis. 13 (2002) 120-128
7. Furuse Y., Suzuki A., Kamigaki T., et al. Reversion of influenza A(H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J. Clin. Microbiol. 47 (2009) 841-844
8. Hayden F.G. Antiviral resistance in influenza viruses-implications for management and pandemic response. N. Engl. J. Med. 354 (2006) 785-788
9. Nelson M.I., Simonsen L., Viboud C., et al. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology 388 (2009) 270-278
10. Saito R., Li D., and Suzuki H. Amantadine-resistant influenza A(H3N2) virus in Japan 2005-2006. N. Engl. J. Med. 356 (2007) 312-313
11. Saito R., Suzuki Y., Li D., et al. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J. Infect. Dis. 197 (2008) 630-632